Trade cancer for...cancer?

I can only imagine that receiving a diagnosis of prostate cancer sets a man's head spinning.

Want to know what sets MY head spinning? Reading about the risky treatments the mainstream tries to pass off as marvels of modern medicine.

One of the more common treatments for prostate cancer is androgen deprivation therapy (ADT), which fights cancer by suppressing male sex hormones. Currently, hundreds of thousands (estimates say about 600,000, in fact) are being treated with ADT for prostate cancer.

University of Michigan Medical School researchers recently examined data from 107,859 prostate cancer patients aged 67 and older. And what they found is, in short, disturbing.

According to their analysis, men treated with ADT had a 30 to 40 percent higher risk of colorectal cancer than men who didn't receive the treatment. The risk increased the longer the men received the therapy.

Now, you might be thinking that this all sounds sort of familiar.

That's because this is the second time in only two months that I've written about the potential dangers of treating cancer with ADT. This might be the first study linking ADT to colon cancer, but it's not the first to point out a scary risk. Last month, I told you about a study that revealed ADT's association with structural bone decay ("ADT for prostate cancer linked to bone decay," 10/21/10).

A potential loss of four to five percent of bone density, and now this news of a 30 to 40 percent higher risk of developing colon cancer...suddenly this oh-so-common treatment is looking like it should go the way of other formerly common medical treatments. You know, like bloodletting and lobotomies.

Share/Save/BookmarkPrinter-friendly versionPrinter-friendly version

About the author

author-picture

Christine O'Brien writes the e-letter Health eTips for Dr. Wright's Nutrition and Healing.

You can sign up for the free eTips at www.wrightnewsletter.com.


Comments

Anonymous's picture
1

esarah bearden

My father had prostate cancer and was given this kind of therapy. His cancer quickly turned into bone cancer and he died. I have often wondered if there was a connection between the drug therapy he received and his bone cancer because usually men live a fairly long time when diagnosed with prostate cancer. My father didn't.

Anonymous's picture
2

Lori

I can't understand why our medical community doesn't realize (or maybe acknowledge) that the body strives to maintain homeostasis on many levels, and that suppressing a natural function can have devestating rebound effects. We see it with cholesterol suppression, hormone suppression, stomach acid suppression, you name it. Recent research, for example, is targeting the appetite hormones leptin and ghrelin in the "fight" against obesity. The hormones are out of whack, they say, so we need to tweak them to prevent obesity. So what about 30 - 40 years ago when there was no obesity epidemic? Same hormones then doing the same thing...And when it comes to cancer, tweaking hormones is not the answer. But we're not really looking for the "answer", we're just looking to manage the disease, buy the patient a little more time, and reap giant profits all the while.

Anonymous's picture
3

Randy Ice PT, CCS

Depriving a man of testosterone is a failed strategy that never cures PCA, and results in a poor quality of life and earlier death. There are at least 5 studies published between 1945 and 1977 that revealed doing just the opposite (administering testosterone) have favorable results in men with PCA. This information has been ignored ever since ADT was introduced in the 1980's and has made a killing (pun intended) for urologists who make as much as $1000/injection of testosterone ablating drugs. The myth that testosterone "feeds" PCA needs to be put into the medical scrapbook of abandoned therapies.

kevinoneall's picture
4

Dr Kevin O'Neall

Dr Yigal Gat in Isreal has come up with a solution to the problem. He's proven that as men age we develop incompent veins which allow blood to pool rather than be moved out of the prostate. That pooling action causes supraphysiologic levels of hormone in the prostate which leads to BPH and ultimately to prostate cancer.

In his office the treatment is simple, requiring no anesthesia. Patients are in and out in two hours, sent home with an icepack.

Doctors have long known of the paradox, that blood levels of testosterone can be low while protate tissue levels are sometimes ten-fold higher. He has shown why this happens and has a proven cure and I'm tearing my hair out because he's received no notice in the U.S. I'm ready to have the procedure today but my insurance company won't allow it.

kpo

Post new comment

The content of this field is kept private and will not be shown publicly.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Allowed HTML tags: <a> <p> <strong> <ul> <ol> <li> <dl> <dt> <dd> <h2> <h3> <u> <em>
  • Lines and paragraphs break automatically.
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.


popitup